verapamil has been researched along with ketanserin in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (29.03) | 18.7374 |
| 1990's | 14 (45.16) | 18.2507 |
| 2000's | 2 (6.45) | 29.6817 |
| 2010's | 5 (16.13) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, Y; Feng, F; He, S; Li, Q; Liao, Q; Liu, W; Liu, Y; Lu, W; Sun, H; Xing, S; Xiong, B; Yang, H | 1 |
| Mustafa, AA | 1 |
| Pillai, G; Sutter, MC | 1 |
| Appell, KC; Barrett, RJ; Kilpatrick, BF; Nolan, JC; Proakis, AG; Walsh, DA | 1 |
| Beubler, E; Hinterleitner, T; Horina, G | 1 |
| Beubler, E; Bukhave, K; Kollar, G; Rask-Madsen, J; Saria, A | 1 |
| Masuyama, Y; Nishio, I; Tsuda, K | 1 |
| Hofmann, HP; Raschack, M; Unger, L | 1 |
| Jaffe, BM; Kimura, K; LaRosa, CA; Money, SR; Pimpl, W; Sherlock, D | 1 |
| Andersson, TL; Larsson, B; Vinge, E | 1 |
| Cerini, R; Hadengue, A; Koshy, A; Lebrec, D; Lee, SS; Moreau, R | 1 |
| Affolter, H; Burkard, WP; Pletscher, A | 1 |
| Olesen, SP | 1 |
| Adachi, H; Shoji, T | 1 |
| Kirchengast, M; Lehmann, HD; Rübsamen, K | 1 |
| Boulanger, CM; Kirchengast, M; Park, SJ; Vanhoutte, PM | 1 |
| Marwood, JF; Okoro, EO; Stokes, GS | 1 |
| López-Novoa, JM; Montero, A; Reverte, M; Rodríguez-López, A | 1 |
| Allegra, A; Aloisi, C; Baldari, S; Buemi, M; Imbesi, D; Laganà, A; Morabito, N; Palella, S; Privitera, M; Villari, C | 1 |
| Nagatomo, T; Shibata, A; Shimada, K; Tsuchihashi, H; Wakabayashi, H; Watanabe, K | 1 |
| Nagatomo, T; Sasaki, K; Shibata, A; Shimada, K; Wakabayashi, H; Watanabe, K | 1 |
| Beaughard, M; Brasset, M; John, G; Massingham, R | 1 |
| Marwood, JF; Okoro, EO | 1 |
| Borda, E; Busch, L; Wald, M | 1 |
1 trial(s) available for verapamil and ketanserin
| Article | Year |
|---|---|
Is erythropoietin-induced hypertension a phenomenon due to the intracellular Ca++ mobilisation?
Topics: Adult; Blood Circulation; Calcium; Erythropoietin; Gallopamil; Humans; Ketanserin; Male; Nifedipine; Recombinant Proteins; Vasoconstrictor Agents; Verapamil | 1994 |
30 other study(ies) available for verapamil and ketanserin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Discovery and Biological Evaluation of a Novel Highly Potent Selective Butyrylcholinsterase Inhibitor.
Topics: Aminoquinolines; Animals; Benzimidazoles; Butyrylcholinesterase; Cell Line, Tumor; Cholinesterase Inhibitors; Drug Discovery; Drug Evaluation, Preclinical; Female; Humans; Male; Mice, Inbred ICR; Microsomes, Liver; Molecular Docking Simulation; Molecular Dynamics Simulation; Neuroprotective Agents; Protein Binding; Small Molecule Libraries | 2020 |
Rapid desensitization of central beta-adrenoceptors in rat after subacute treatment with imipramine and calcium entry blockers.
Topics: 1-Propanol; Animals; Calcium Channel Blockers; Clonidine; Diltiazem; DOM 2,5-Dimethoxy-4-Methylamphetamine; Drinking Behavior; Fenclonine; Imipramine; Isoproterenol; Ketanserin; Nicardipine; Nifedipine; Oxidopamine; Rats; Receptors, Adrenergic, beta; Verapamil | 1991 |
Effect of human plasma proteins on spontaneous contractile activity of rat mesenteric portal vein.
Topics: Alpha-Globulins; Animals; Atropine; Beta-Globulins; Blood Proteins; Chlorpheniramine; gamma-Globulins; Humans; Immunoglobulin G; Ketanserin; Male; Mesenteric Veins; Muscle Contraction; Muscle, Smooth, Vascular; Ouabain; Phentolamine; Portal Vein; Rats; Rats, Inbred Strains; Saralasin; Serum Albumin; Verapamil | 1990 |
AHR-16303B, a novel antagonist of 5-HT2 receptors and voltage-sensitive calcium channels.
Topics: Animals; Atrial Function; Blood Pressure; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Chloride; Diuresis; Dose-Response Relationship, Drug; Edema; Guinea Pigs; Heart Atria; Ketanserin; Male; Muscle Contraction; Muscle, Smooth, Vascular; Myocardial Contraction; Nimodipine; Piperidines; Platelet Aggregation; Propiophenones; Rabbits; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Receptors, Dopamine; Receptors, Histamine H1; Receptors, Serotonin; Reflex; Serotonin; Serotonin Antagonists; Tritium; Verapamil | 1991 |
Protein kinase C and intestinal fluid secretion: involvement of prostaglandin E2 but not of 5-hydroxytryptamine.
Topics: Animals; Body Fluids; Cyclic AMP; Dinoprostone; Dose-Response Relationship, Drug; Female; Indomethacin; Intestinal Mucosa; Jejunum; Ketanserin; Protein Kinase C; Rats; Rats, Inbred Strains; Serotonin; Tetradecanoylphorbol Acetate; Verapamil | 1990 |
Involvement of 5-hydroxytryptamine, prostaglandin E2, and cyclic adenosine monophosphate in cholera toxin-induced fluid secretion in the small intestine of the rat in vivo.
Topics: Animals; Body Fluids; Cholera Toxin; Cyclic AMP; Dinoprostone; Dose-Response Relationship, Drug; Female; Indomethacin; Intestine, Small; Ketanserin; Nifedipine; Rats; Rats, Inbred Strains; Serotonin; Time Factors; Verapamil | 1989 |
Effects of ketanserin, verapamil and diltiazem on vascular sympathetic nerve activity in hypertension.
Topics: Animals; Blood Pressure; Diltiazem; Dose-Response Relationship, Drug; Electric Stimulation; Hypertension; Ketanserin; Norepinephrine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Sympathetic Nervous System; Verapamil | 1989 |
(S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 1st communication: pharmacological profile.
Topics: Animals; Binding, Competitive; Calcium Channel Blockers; Cerebrovascular Disorders; Female; Guinea Pigs; In Vitro Techniques; Ischemic Attack, Transient; Ketanserin; Male; Membranes; Mice; Muscle, Smooth, Vascular; Muscles; Myocardial Contraction; Rats; Rats, Inbred Strains; Serotonin Antagonists; Verapamil | 1989 |
The role of serotonin in the canine secretory response to cholera toxin in vivo.
Topics: Animals; Body Water; Cholera Toxin; Dogs; Electrolytes; Intestinal Secretions; Ketanserin; Serotonin; Verapamil | 1989 |
Effects of some calcium antagonists on aggregation by adrenalin and serotonin and on alpha-adrenoceptor radioligand binding in human platelets.
Topics: Adrenergic alpha-Antagonists; Calcium Channel Blockers; Diltiazem; Epinephrine; Humans; Ketanserin; Nifedipine; Phentolamine; Platelet Aggregation; Radioligand Assay; Serotonin; Verapamil; Yohimbine | 1988 |
Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: search for an additive effect.
Topics: Drug Synergism; Drug Therapy, Combination; Hemodynamics; Humans; Hypertension, Portal; Ketanserin; Liver Cirrhosis, Alcoholic; Propranolol; Splanchnic Circulation; Time Factors; Verapamil | 1989 |
Verapamil, an antagonist at 5-hydroxytryptamine receptors of human blood platelets.
Topics: Adenosine Diphosphate; Binding, Competitive; Blood Platelets; Cerebral Cortex; Gallopamil; Humans; In Vitro Techniques; Ketanserin; Membranes; Piperidines; Receptors, Serotonin; Spiperone; Verapamil | 1985 |
A calcium-dependent reversible permeability increase in microvessels in frog brain, induced by serotonin.
Topics: Animals; Blood-Brain Barrier; Brain; Calcium; Capillary Permeability; Dose-Response Relationship, Drug; Electric Conductivity; Endothelium; Ketanserin; Piperidines; Rana temporaria; Serotonin; Serotonin Antagonists; Verapamil | 1985 |
Characteristics of the inhibition of ligand binding to serotonin receptors in rat brain membranes by verapamil.
Topics: Animals; Binding, Competitive; In Vitro Techniques; Ketanserin; Male; Membranes; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, Serotonin; Verapamil | 1986 |
Inhibition by the combined Ca2+ and 5-HT2 receptor antagonist nexopamil (LU 49938) of intracoronary thrombus formation in a canine model of arterial stenosis and intimal damage.
Topics: Animals; Calcium; Coronary Circulation; Coronary Thrombosis; Dogs; Female; Gallopamil; Hemodynamics; Injections, Intravenous; Ketanserin; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Serotonin Antagonists; Verapamil | 1993 |
Effects of the combined 5-hydroxytryptamine2 receptor and Ca2+ channel antagonist LU49938 on the responsiveness of isolated porcine coronary arteries with and without endothelium.
Topics: Analysis of Variance; Animals; Calcium-Binding Proteins; Coronary Vessels; Dinoprost; Dose-Response Relationship, Drug; Endothelium, Vascular; In Vitro Techniques; Ketanserin; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Serotonin; Serotonin Antagonists; Swine; Verapamil | 1994 |
Interaction between Ca2+, verapamil, and ketanserin in rat tail artery and aorta.
Topics: Animals; Aorta, Thoracic; Arteries; Calcium; In Vitro Techniques; Ketanserin; Male; Muscle Contraction; Muscle, Smooth, Vascular; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Regional Blood Flow; Serotonin; Serotonin Antagonists; Tail; Verapamil | 1995 |
The effect of LU-49938 (nexopamil) on the activation by serotonin of mesangial cells.
Topics: Animals; Cell Count; Cell Division; Cells, Cultured; Dose-Response Relationship, Drug; Glomerular Mesangium; Ketanserin; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Thymidine; Time Factors; Verapamil | 1995 |
Alterations of binding characteristics of alpha 1-,beta 1-adrenoceptors and Ca2+ binding sites in the myocardium of spontaneously hypertensive rats (SHR) by chronically administered bunazosin, atenolol, ketanserin and verapamil.
Topics: Adrenergic alpha-Antagonists; Animals; Atenolol; Binding Sites; Blood Pressure; Calcium Channels; Heart; In Vitro Techniques; Ketanserin; Kinetics; Myocardium; Norepinephrine; Quinazolines; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Verapamil | 1993 |
Cardiomyopathic hamster hearts: long-term effects of drugs on catecholamine contents and binding characteristics of alpha 1- and beta 1-adrenergic receptors.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Cardiomyopathies; Catecholamines; Cricetinae; Heart; Ketanserin; Mesocricetus; Myocardium; Propanolamines; Radioligand Assay; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Verapamil; Xamoterol | 1993 |
Failure of calcium channel blockade to reduce platelet-mediated cyclic flow variations in dogs with coronary stenosis and endothelial injury.
Topics: Animals; Aspirin; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Diltiazem; Disease Models, Animal; Dogs; Endothelium, Vascular; Female; Heart Block; Infusions, Intravenous; Ketanserin; Male; Nifedipine; Platelet Aggregation; Platelet Aggregation Inhibitors; Thrombosis; Vasodilator Agents; Verapamil | 1995 |
Effects of 5HT2 receptor antagonists on responses to potassium depolarization in rat isolated aorta.
Topics: Animals; Aorta, Thoracic; Cinnarizine; Cyproheptadine; Diltiazem; Drug Synergism; Felodipine; Female; In Vitro Techniques; Ketanserin; Male; Mianserin; Muscle Contraction; Nifedipine; Potassium; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Reproducibility of Results; Ritanserin; Serotonin Antagonists; Verapamil | 1997 |
Long-term treatment with fluoxetine associates with peripheral effects on rat vas deferens contractility.
Topics: Adrenergic Agents; Animals; Antidepressive Agents, Second-Generation; Binding Sites; Calcium; Cyclooxygenase Inhibitors; Fluoxetine; Indomethacin; Isoproterenol; Ketanserin; Male; Muscle Contraction; Nitroprusside; Norepinephrine; Prazosin; Rats; Rats, Wistar; Serotonin; Serotonin Antagonists; Vas Deferens; Verapamil | 1999 |